| Literature DB >> 18194354 |
Orli Megged1, Itamar Shalit, Isaac Yaniv, Jerry Stein, Salvador Fisher, Itzhak Levy.
Abstract
We describe a case of breakthrough cerebral toxoplasmosis during atovaquone therapy in a child who was intolerant of conventional prophylactic regimens after hematopoietic stem cell transplantation. The available data on the efficacy of atovaquone prophylaxis in Toxoplasma sero-positive stem cell transplant recipients remain limited, and other strategies, such as preemptive strategy using toxoplasma PCR or TMP-SMX desensitization should be considered in this setting.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18194354 DOI： 10.1111/j.1399-3046.2007.00891.x
Source DB: PubMed Journal: Pediatr Transplant ISSN： 1397-3142